Nuvectis Pharma Inc (NVCT)
7.65 +0.13 (+1.73%) 11:48 ET [NASDAQ]
7.53 x 100 7.65 x 90
Realtime by (Cboe BZX)
7.53 x 100 7.65 x 90
Realtime 7.40 -0.12 (-1.60%) 06:24 ET
for Fri, Feb 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Operating Expenses | 4,359 | 4,643 | 4,396 | 6,866 | 6,158 |
Operating Income | -4,359 | -4,643 | -4,396 | -6,866 | -6,158 |
Other Income | 206 | 215 | 225 | 244 | 277 |
Pre-tax Income | -4,153 | -4,428 | -4,171 | -6,622 | -5,881 |
Net Income Continuous | -4,153 | -4,428 | -4,171 | -6,622 | -5,881 |
Net Income | $-4,153 | $-4,428 | $-4,171 | $-6,622 | $-5,881 |
EPS Basic Total Ops | -0.24 | -0.26 | -0.25 | -0.41 | -0.37 |
EPS Basic Continuous Ops | -0.24 | -0.26 | -0.25 | -0.41 | -0.37 |
EPS Diluted Total Ops | -0.24 | -0.26 | -0.25 | -0.41 | -0.37 |
EPS Diluted Continuous Ops | -0.24 | -0.26 | -0.25 | -0.41 | -0.37 |
EPS Diluted Before Non-Recurring Items | -0.24 | -0.26 | -0.25 | -0.41 | -0.37 |
EBITDA(a) | $-4,359 | $-4,643 | $-4,396 | $-6,866 | $-6,158 |